• Users Online: 252
  • Print this page
  • Email this page


 
 
Table of Contents
ORIGINAL ARTICLE
Year : 2019  |  Volume : 7  |  Issue : 2  |  Page : 65-71

The biological and hematological effects of Echinacea purpurea L. Roots extract in the immunocompromised rats with cyclosporine


1 Department of Food and Nutrition, Faculty of Home Economics, King Abdulaziz University, Jeddah, Saudi Arabia; Department of Nutrition and Food Science, Faculty of Home Economics, Helwan University, Cairo, Egypt
2 Department of Anatomy, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia; Department of Histology and Cell Biology, Faculty of Medicine, Ain Shams University, Cairo, Egypt
3 Department of Food and Nutrition, Faculty of Home Economics, King Abdulaziz University, Jeddah, Saudi Arabia

Date of Web Publication13-Jun-2019

Correspondence Address:
Seham K Abounasef
Professor of Histology and Cell Biology, Department of Histology and Cell Biology, Faculty of Medicine, Ain Shams University, Cairo

Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/JMAU.JMAU_62_18

Get Permissions

  Abstract 


Background: The immune system is the body's defense against foreign organisms and harmful chemicals. Cyclosporine A (CsA) is an immunosuppressant drug widely used. Echinacea purpurea root (EPR) extract is used as an immunostimulant plant. Aim of the Work: The present study aimed at evaluation of the EPR effects against the CsA immunosuppressive rat model. Material and Methods: Thirty-two male Wistar albino rats were randomly divided into control, CsA (immunosuppressive models), CsA + EPR (100 mg/kg/day orally), and CsA + EPR (200 mg/kg/day orally). The biological parameters regarding the food consumption were assessed including feed intake (FI), feed efficiency ratio (FER), and body weights (BW). In addition, the splenic specimens were assessed histopathology. The blood was collected for measuring the blood parameters. All the measured parameters were collected and statistically analyzed. The biological results indicated a significant decrease in BW, FI, and FER in rats treated orally with low and high EPR doses as compared to the control group. Results: The results displayed that the CsA induced a significant decrease in red blood cells (RBCs) and white blood cells (WBCs) count. Histopathologically, CsA induced a marked decrease in the cellularity of the white pulp with congested blood sinusoids of the red pulp together with significant depletion of periarteriolar lymphoid sheath. Both the high and low doses of EPR significantly reversed the altered RBCs and WBCs counts. Histopathologically, both the low and high doses of EPR displayed apparently increase in the periarteriolar area together with the persistence of the congestion of the red pulp blood sinusoids compared to CsA group, indicating partial amelioration of the structural changes. Conclusion: In a nutshell, the current findings revealed that EPR extract ameliorated the hematological changes. However, there was a partial correction of the CsA-induced microscopic changes of the rat spleen.

Keywords: Cyclosporine, Echinacea purpurea roots, immunosuppression, rat, spleen


How to cite this article:
H. Khattab HA, Abounasef SK, Bakheet HL. The biological and hematological effects of Echinacea purpurea L. Roots extract in the immunocompromised rats with cyclosporine. J Microsc Ultrastruct 2019;7:65-71

How to cite this URL:
H. Khattab HA, Abounasef SK, Bakheet HL. The biological and hematological effects of Echinacea purpurea L. Roots extract in the immunocompromised rats with cyclosporine. J Microsc Ultrastruct [serial online] 2019 [cited 2019 Sep 19];7:65-71. Available from: http://www.jmau.org/text.asp?2019/7/2/65/260237




  Introduction Top


Echinacea purpurea L. is a medicinal plant that belongs to the family Asteraceae, commonly known as the purple coneflower.[1] The most commonly used preparation is a liquid extract made from the root of E. purpurea.[2] It contains various biologically active compounds including polysaccharides, polyacetylenes, flavonoids, alkamides, caffeic acid derivatives, and cichoric acid, which is the major active compound.[3]

E. purpurea has been used in the prevention and treatment of different pathological conditions.[4] It has wound-healing properties[5] and anti-inflammatory[6] and antioxidant activities.[7] Echinacea potentiates the immune system through activation of the macrophages, polymorphonuclear leukocytes, and natural killer cells. It was used as prevention or treatment of some diseases including influenza and common cold.[8]

The effect of E. purpurea against gamma radiation-induced oxidative stress and immune responses in male rats was investigated. The results showed that total white cell, lymphocytes, neutrophils, and monocytes were significantly lower in irradiated rats, compared with their corresponding levels in the control group. E. purpurea supplementation has significantly ameliorated these decreases. Thus, E. purpurea is shown to have a radioprotective effect against gamma irradiation by preventing oxidative stress in the spleen tissues and modulation of immune responses.[9]

Cyclosporine (CsA) is an immunosuppressant drug widely used in organ transplantation to prevent rejection in people with organ transplants. In spite of its therapeutic effects, it has many adverse effects, such as anemia, thrombocytopenia, and increased liability to various infections.[10] It reduces the immune system activity by interfering with the activity and growth of T-cell and decreasing the production of lymphocytes.

Immunosuppressive drugs play an important role in anemia. Reduction in the white blood cells (WBCs), the red blood cell counts, and the hemoglobin (Hb) concentration, with an increase in the platelet counts, were observed in rats treated with CsA at a daily oral dose of 7.5 mg/kg.[11] In addition, administration of CsA (30 mg/kg) and ketoconazole (10 mg/kg) drugs induced significantly decrease in total WBC and lymphocyte counts compared to control animal.[12] Another study revealed that the treatment with cyclosporine daily doses (low, 2 mg/kg; medium 5 mg/kg, and high 10 mg/kg) for 31 days suppressed white cells count and lymphocytes and inhibited cell-mediated immunity in dose-dependent manner compared with untreated group.[13]

In addition, in another study, rats were daily treated with CsA (5 mg/kg body weight [BW]), and the blood hematology was evaluated after 7 weeks of treatment. CsA-treated rats showed that a noticeable reduction in red blood cells (RBCs), hematocrit, Hb concentration, mean platelet volume, and platelet distribution width were significantly observed in both groups under immunosuppressive treatment compared with the control group.[14] Female rats received CsA (5 mg/kg/day by oral gavage) for 2 weeks showed that many subpopulations of suppressed lymphocytes. Moreover, qualitative, quantitative, and morphological changes of the immune system in pharmacologically immunosuppressed females have been observed.[15]

In the way of finding a natural dietary supplement trying to decrease the side effects of immunosuppressive drugs before and after their therapeutic use. The present study aimed at evaluation of the impact of the low and high doses of EPR on CsA-induced immunosuppression on the blood parameters and microscopic changes of the spleen in the male rats.


  Materials and Methods Top


Drugs and plant

E. purpurea root (EPR) liquid extract (USDA Organic) was purchased from iHerb.com, Herb Pharm, Saudi Arabia. The country of origin of goods was the USA.

Cyclosporine (CsA) 50 mg/ml (Sandimmune-Novartis) was obtained from King Abdul-Aziz University Hospital. The content of the capsules was dissolved in glycol and freshly prepared for subcutaneous (SC) injection depending on the weight of each animal.

Experimental animals

Wistar albino male rats (n = 32 rats) ranged from 170 to 210 g were obtained from the animal experimental unit of King Fahd Center for Medical Research (KFMRC), King Abdul-Aziz University (KAU). All animals were allowed to acclimatize for 1 week in animal housing conditions before being used for the study. The rats were housed in standard laboratory conditions at a temperature of (22°C ± 3°C), relative humidity (50%–55%) and a 12-h light/dark cycle (4 rats/cage). All animals were fed on the standard balanced diet according to Reeves et al.[16] and drinking water ad libitum, following the protocols, that were approved by the Ethical Committee for Animal Care of the KAU, Jeddah, Saudi Arabia, which are in accordance with the guidelines of the Canadian Council on Animal Care.

Diet formula

Standard balanced diet was obtained from KFMRC, KAU, Jeddah, Saudi Arabia. The basic diet consists of the following ingredients: crude protein (casein) 20%; crude fat 4.0%; sucrose 10%; corn oil 4%; choline chloride 0.2%; vitamin mixture 1%; salt mixture 3.5%; fibers (cellulose) 5%; and the remainder being corn starch up to 100%. The diet manufactured by Grain Silos and Flour Mills Organization, KSA.

Methods

Induction of immunosuppression by cyclosporine

Immunosuppression was induced by CsA. Rats were injected with CsA SC at a dose level of (15 mg/kg) for 21 days.[17]

Experimental design

The rats were randomly divided into the following four groups (8 each): Group I (control): The animals were injected with the glycol (the solvent used for dilution of cyclosporine) SC daily for the 21 days. Group II (immunosuppressive models): The rats were injected with a daily single SC dose of CsA as previously mentioned. Group III and IV (CsA + EPR) (protected groups): The animals were ingested EPR extract of 100 or 200 mg/kg, orally, daily, respectively. The chosen dose (100 mg/kg, orally, daily) was according to a previous study.[18] Then, the rats of both groups were injected SC with the daily single dose of CsA as previously mentioned.

Biological evaluation

Daily feed intake (FI) per group was calculated throughout the experimental period (21 days). The feed efficiency ratio (FER) was calculated using the following equation according to the method of Chapman et al. FER = Gain in body weight (g)/food consumed (g).

At the end of the experimental period, all rats were fasted overnight and then sacrificed. The final BW was recorded and used for calculation of the body weight gain percent (BWG%). BWG% was calculated at the end of the experimental period according to the following equations.[19]



Hematological study

Blood samples were immediately collected from the retro-orbital plexus of veins into the sterile heparin-coated tubes using the capillary tubes under mild ether anesthesia. The RBC parameters included total RBCs count, Hb, and mean corpuscular hemoglobin (MCH). The WBC parameters included the total WBCs and lymphocyte differential counts. The analysis was done at AL-Borg Medical Laboratory (Jeddah, Saudi Arabia) using rat detection kit by the auto-hematology analyzer ROCHE (Sysmex XS-500i).

Histopathological studies

By the end of the experiment, the spleen was dissected and washed with a cold saline solution and dried between two filter papers and then weighed. The organs were trimmed and preserved in phosphate-buffered formalin for the tissue processing and embedding in the paraffin. The sections stained with hematoxylin and eosin (H and E) to assess the microscopic changes.

Statistical analysis

Results were expressed as a mean ± standard error. Data were analyzed statistically by one-way analysis of variance followed by LSD test being used for determining the significances among different groups at a level of <0.05. A DELL computer with a software system SPSS version 16 (SPSS Inc., Chicago, IL, U.S.A.) (installed from the Saudi Digital Library) was used for these calculations.


  Results Top


Biological evaluation

The changes in the BW, BWG%, FI, and FER in different groups are summarized in [Table 1] and [Histogram 1]. The results revealed that there was no significant difference in initial BW between all the experimental groups. There was a significant decrease (−9.88%) (P < 0.05) in the final BW and the BWG% in CsA group compared to the control. After 21 days, CsA + EPR (100 mg/kg/BW) and CsA + EPR (200 mg/kg/BW) groups showed a significant (P ≤ 0.001) reduction in final BW and BWG% as compared to the control group. On the other hand, there was a significant difference in final BW and BWG% between CsA group and both CsA + EPR at low and high doses.
Table 1: Effect of Echinacea purpurea root (100 and 200 mg/kg body weight) on the biological evaluation parameters among different groups

Click here to view



Hematological study

The statistical analysis of the hematological parameters is summarized in [Table 2] and [Histogram 2]. The results revealed that, in the CsA group, Hb level was significantly lower (P < 0.001) than in the control group (9.85 ± 0.82 and 14.97 ± 0.77 g/dl, respectively). On the other hand, there was a significant increase (P < 0.001) in Hb level in EPR-treated groups (100 and 200 mg/kg) when compared with CsA group. The level of Hb returned to nearly normal range in treated groups. Concerning RBCs, CsA rats showed a significant decrease (P < 0.05) in RBCs count as compared with the control group; whereas treated rats with low and high dose of EPR displayed insignificant elevation when compared with CsA group (mean values 8.40 ± 0.22 and 8.24 ± 0.17 vs. 7.86 ± 0.20, respectively).
Table 2: Effect of Echinacea purpurea root (100 and 200 mg/kg) on some hematological parameters in different groups

Click here to view



Furthermore, data revealed that CsA group caused a significant reduction (23.03%) (P < 0.001) in MCH as compared with control group. Oral administration of EPR induced significant (P < 0.001) amelioration in treated groups as compared with CsA group.

Concerning the level of WBCs, there was significantly decreased (P < 0.001) in CsA group with a mean value of 1.94 ± 0.14 when compared to the control group with a mean value of 6.17 ± 0.53. Oral administration of EPR with low and high doses to CsA-injected rats induced significant (P < 0.001) elevation in WBCs as compared with CsA group.

At the same time, there was a significant decrease (P < 0.05) in lymphocytes when compared between control group and CsA group, with the mean values being 2.30 ± 0.17 vs. 1.76 ± 0.08 for control and CsA group, respectively. The improvement in high dose of EPR (200 mg/kg) had a significant difference (P < 0.01) when compared with CsA group. Further, there was no significant difference between low doses of EPR (100 mg/kg) and CsA group. As seen in this experiment, treatment with EPR had positive effects on rat's lymphocytes count.

Microscopic examination

Examination of the control spleen sections stained by H and E showed the embedded follicular lymphatic tissues (white pulp) in the highly vascular (red pulp). The white pulp was subdivided into periarterial lymphatic sheath (PALS) around the central artery, follicular areas, and the marginal zones between white and red pulp. The PALS could be demarcated as the area around the central artery. The red pulp displayed a reticular network of splenic cords and in between the venous blood sinusoids [Figure 1]a. The spleen sections from CsA group revealed a marked decrease in the cellularity of PALS. The congested blood sinusoids in both the white and red pulp were the prominent feature in most of the examined sections together with thickened trabeculae [Figure 1]b. In the CsA groups treated with low and high dose of EPR, the PALS area had an apparent increase compared to the cyclosporine-treated group (CsA) together with the persistence of the congestion of the red pulp blood sinusoids. The higher magnification revealed the prominence of the medium and large lymphocytes on the expense of the small lymphocytes, especially in the marginal zone [Figure 1]c and [Figure 1]d.
Figure 1: Photomicrographs of the rat spleen. (a) A control one showing the parenchyma with aggregation of lymphocytes around the arteriole (A) in the white pulp, marginal zone (M) around it and the different cell series in the red pulp (R). (b). a rat spleen from the CsA group, showing marked decrease in the lymphocytes in the periarteriolar area of the white pulp (w). Notice the marked increase in dilated sinusoids with difficult demarcation between different zones. (c) A rat spleen from CsA + Echinacea purpurea root (100 mg/kg BW) group, showing the active germinal center (GC) of the white pulp with predominance of the cell nest appearance of the macrophages (⟶) and increased number of large macrophages (▸) in the marginal zone (M). (d) a rat spleen from CsA + Echinacea purpurea root (200 mg/kg BW) group, showing the increased number of activated lymphocytes in the marginal zone (M). Arteriole (A) and white pulp (W). Bar 50 μ (H and E stain)

Click here to view



  Discussion Top


Cyclosporine A (CsA) is considered one of the common worldwide immunosuppressive drugs that are used to prevent the allograft rejection in organ transplantation. It has been given for the treatment of autoimmune diseases such as psoriasis and rheumatoid arthritis. Their side effects have been attributed to the increase production of reactive oxygen species and the altered antioxidant status. Treatment with CsA inhibits the expression and activity of antioxidant enzymes. Thus, administration of the antioxidant supplementation with CsA treatment might be beneficial to prevent severe side effects.

One of the observations in the current study was the significant decrease of BW after ERP intake. This can be explained by the change of one of its metabolites (alkamides) to caffeine during its metabolism and this may be a cause of appetite decrease. In the present study, administration of EPR- to CsA-injected rats induced a significant decrease in final BW, BWG%, and FI compared with the control group. The obtained results were in agreement with previous authors.[20] These results may be attributed to the synergistic effect of EPR-induced anorexia with the toxicity of CsA, resulting in further reduction in the FI. In contrast, other studies reported that Echinacea has a positive effect on BW gain after 4 weeks of treatment. The difference could be attributed to study design including the dose and the duration of experiment.[21],[22]

The current reduction of the total WBCs and differential lymphocytic counts together with a decrease in RBCs count and Hb concentration were consistent with the study of Lekhooa.[13] This reduction was previously explained by the reduced erythropoietin production, resulting in the decreased stimulation of bone marrow erythropoiesis.[23] Meanwhile, administration of EPR- to CsA-injected rats presented a significant correction in all hematological parameters, showing a significant difference between the low and high dose-treated groups. These findings were in accordance with those reported previously by many authors[9],[21],[24],[25] This improvement attributed to the contents of E. purpurea as cichoric acid and echinacin, where each stimulates bone marrow and hematopoietic stem cells as mentioned in a previous study.[26]

The increase in the leukocyte count was a similar finding by other studies.[22],[27] This result could be explained by the ability of polysaccharides and echinacocide to increase the number of leukocytes and the ability of cichoric acid and echinacin to activate macrophages and stimulate bone marrow. In addition, it was found that Echinacea- induced changes in the percentage of lymphocyte subpopulations indicated that Echinacea might modulate both innate and adaptive immune functions.[5]

Oxidative stress-induced tissues damage can be ameliorated by lower oxidative stress status. Antioxidants act as radical scavenger and inhibit lipid peroxidation and other free radicals-mediated processes, thereby protecting the human body from various diseases.[28] In the present study, the protective effect of EPR involves in the maintenance of antioxidant capacity for protecting the tissues against oxidative stress. This positive improvement may be attributed to the mechanism of antioxidant activity of EPR-included free radicals scavenging and transition metal chelating.[29] The superoxide dismutase activity in the blood was increased because of antioxidants compounds such as echinacocide and caffeine acid in E. purpurea which eliminate superoxide by free radicals scavenging effect as explained in a previous study.[30] Furthermore, analysis of E. purpurea extracts illuminated that it contains a series of active compounds as caffeic acid and polyphenolics including cichoric acid and glycosylated flavonoids and polysaccharides, which is responsible for certain anti-inflammatory and antioxidant activities.[31]

However, other studies mentioned opposite findings compared to the current one;[5],[32],[33] this could be attributed to the drugs used in the research, duration of the experiment, and extraction methods.

Finally, the current findings revealed that EPR extract ameliorated the hematological changes. However, there was a partial correction of the CsA-induced microscopic changes of the rat spleen. Biologically, it may be a BW decreasing agent, which carries a chance for medicinal pharmacists searching for new drug discovery.

Acknowledgements

We acknowledge with thanks the support of King Abdulaziz City for Science and Technology (KACST) for their financial and logistical support and for providing necessary guidance concerning projects implementation of the Research No. AT-37-1943.

Ethics approval

The animal protocol of the study was approved by the local committee for animal care (KACST, Jeddah, Saudi Arabia; Protocol No. AT-37-1943) and was in accordance with the National Institutes of Health guidelines for the use of live animals (NIH publication No. 85-23, revised 1996). Further, the fund body had approved the proposal for this study.

Financial support and sponsorship

We acknowledge with thanks the support of KACST for their financial and logistical support and for providing necessary guidance concerning projects implementation of the Research No. AT-37-1943.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Kumar K, Ramaiah S. Pharmacological importance of Echinacea purpurea. Int J Pharm Biol Sci 2011;2:304-14.  Back to cited text no. 1
    
2.
Kligler B. Echinacea. Am Fam Physician 2003;67:77-80.  Back to cited text no. 2
    
3.
Bauer Ra, Wagner H. Echinacea species as potential immunostimulatory drugs. 1991.  Back to cited text no. 3
    
4.
Mistrikova I, Vaverkova S. Echinacea- chemical composition, immunostimulatory activities and uses. Thaiszia J Bot 2006;16:11-26.  Back to cited text no. 4
    
5.
Zhai Z. Immunomodulatory, Anti-Inflammatory and Wound Healing Properties of Echinacea Species, Ph.D. Thesis, Iowa State University, Ames, Iowa. 2008.  Back to cited text no. 5
    
6.
Yu D, Yuan Y, Jiang L, Tai Y, Yang X, Hu F, et al. Anti-inflammatory effects of essential oil in Echinacea purpurea L. Pak J Pharm Sci 2013;26:403-8.  Back to cited text no. 6
    
7.
Jukić H, Habeš S, Aldžić A, Durgo K, Kosalec I. Antioxidant and prooxidant activities of phenolic compounds of the extracts of Echinacea purpurea (L.). Bull Chem Technol Bosn Herzegovina 2015;44:43-52.  Back to cited text no. 7
    
8.
Barrett B. Medicinal properties of Echinacea: A critical review. Phytomedicine 2003;10:66-86.  Back to cited text no. 8
    
9.
Ezz M. The ameliorative effect of Echinacea purpurea against gamma radiation induced oxidative stress and immune responses in male rats. Aust J Basic Appl Sci 2011;5:506-12.  Back to cited text no. 9
    
10.
BC Renal Agency Cyclosporine (Neoral ®) Medication Info Sheet. 2013. Available from: http://www.bcrenalagency.ca/resourcegallery/Documents/Cyclosporine%20(Neoral).pdf. [Last accessed on 2013 Jan].  Back to cited text no. 10
    
11.
Pally C, Tanner M, Rizvi H, Papageorgiou C, Schuurman HJ. Tolerability profile of sodium mycophenolate (ERL080) and mycophenolate mofetil with and without cyclosporine (Neoral) in the rat. Toxicology 2001;157:207-15.  Back to cited text no. 11
    
12.
Jivrajani M, Shaikh MV, Shrivastava N, Nivsarkar M. An improved and versatile immunosuppression protocol for the development of tumor xenograft in mice. Anticancer Res 2014;34:7177-83.  Back to cited text no. 12
    
13.
Lekhooa M. Development of a Model to Characterize the Effect of Phela on Selected Immune Markers in Immune-Suppressed rats. University of the Free State, Pharmacology; 2015.  Back to cited text no. 13
    
14.
Reis F, Parada B, Teixeira de Lemos E, Garrido P, Dias A, Piloto N, et al. Hypertension induced by immunosuppressive drugs: A comparative analysis between sirolimus and cyclosporine. Transplant Proc 2009;41:868-73.  Back to cited text no. 14
    
15.
Kabat-Koperska J, Kolasa-Wołosiuk A, Wojciuk B, Wojciechowska-Koszko I, Roszkowska P, Krasnodębska-Szponder B, et al. Changes in the immune system of female wistar rats after exposure to immunosuppressive treatment during pregnancy. Scand J Immunol 2016;83:418-26.  Back to cited text no. 15
    
16.
Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad Hoc Writing Committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993;123:1939-51.  Back to cited text no. 16
    
17.
Rezzani R, Rodella L, Bianchi R. Melatonin antagonises the cyclosporine A immunosuppressive effects in rat thymuses. Int Immunopharmacol 2001;1:1615-9.  Back to cited text no. 17
    
18.
Rezaie A, Fazlara A, Haghi Karamolah M, Shahriari A, Najaf Zadeh H, Pashmforosh M, et al. Effects of Echinacea purpurea on hepatic and renal toxicity induced by diethylnitrosamine in rats. Jundishapur J Nat Pharm Prod 2013;8:60-4.  Back to cited text no. 18
    
19.
Chapman DG, Castillo R, Campbell JA. Evaluation of protein in foods. I. A method for the determination of protein efficiency ratios. Can J Biochem Physiol 1959;37:679-86.  Back to cited text no. 19
    
20.
Nematalla KH, Arafa SA, Yousef GM, Zainb A. Effect of Echinacea as antioxidant on markers of aging. Aust J Basic Appl Sci 2011;5:18-26.  Back to cited text no. 20
    
21.
Skaudickas D, Kondrotas AJ, Baltrusaitis K, Vaitiekaitis G. Effect of Echinacea (Echinacea purpurea L. Moench) preparations on experimental prostate gland. Medicina (Kaunas) 2003;39:761-6.  Back to cited text no. 21
    
22.
Ali EH. Protective effects of Echinacea on cyproterone acetate induced liver damage in male rats. Pak J Biol Sci 2008;11:2464-71.  Back to cited text no. 22
    
23.
Nielsen FT, Jensen BL, Marcussen N, Skøtt O, Bie P. Inhibition of mineralocorticoid receptors with eplerenone alleviates short-term cyclosporin a nephrotoxicity in conscious rats. Nephrol Dial Transplant 2008;23:2777-83.  Back to cited text no. 23
    
24.
Chaves F, Chacón M, Badilla B, Arévalo C. Effect of Echinacea purpurea (Asteraceae) aqueous extract on antibody response to bothrops asper venom and immune cell response. Rev Biol Trop 2007;55:113-9.  Back to cited text no. 24
    
25.
Dehkordi SH, Fallah V. Enhancement of broiler performance and immune response by Echinacea purpurea supplemented in diet. Afr J Biotechnol 2011;10:11280-6.  Back to cited text no. 25
    
26.
Goel V, Chang C, Slama JV, Barton R, Bauer R, Gahler R, et al. Alkylamides of Echinacea purpurea stimulate alveolar macrophage function in normal rats. Int Immunopharmacol 2002;2:381-7.  Back to cited text no. 26
    
27.
Agnew LL, Guffogg SP, Matthias A, Lehmann RP, Bone KM, Watson K, et al. Echinacea intake induces an immune response through altered expression of leucocyte hsp70, increased white cell counts and improved erythrocyte antioxidant defences. J Clin Pharm Ther 2005;30:363-9.  Back to cited text no. 27
    
28.
Marsoul RD, Abbood RM, Abbas MT. Effect of garlic oil on cyclosporine induced renal toxicity in rats. Hum J 2016;5:209-21.  Back to cited text no. 28
    
29.
Hu C, Kitts DD. Studies on the antioxidant activity of Echinacea root extract. J Agric Food Chem 2000;48:1466-72.  Back to cited text no. 29
    
30.
Mishima S, Saito K, Maruyama H, Inoue M, Yamashita T, Ishida T, et al. Antioxidant and immuno-enhancing effects of Echinacea purpurea. Biol Pharm Bull 2004;27:1004-9.  Back to cited text no. 30
    
31.
Turner RB, Bauer R, Woelkart K, Hulsey TC, Gangemi JD. An evaluation of Echinacea angustifolia in experimental rhinovirus infections. N Engl J Med 2005;353:341-8.  Back to cited text no. 31
    
32.
Sasagawa M, Cech NB, Gray DE, Elmer GW, Wenner CA. Echinacea alkylamides inhibit interleukin-2 production by Jurkat T cells. Int Immunopharmacol 2006;6:1214-21.  Back to cited text no. 32
    
33.
Matthias A, Banbury L, Bone KM, Leach DN, Lehmann RP. Echinacea alkylamides modulate induced immune responses in T-cells. Fitoterapia 2008;79:53-8.  Back to cited text no. 33
    


    Figures

  [Figure 1]
 
 
    Tables

  [Table 1], [Table 2]



 

Top
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
Abstract
Introduction
Materials and Me...
Results
Discussion
References
Article Figures
Article Tables

 Article Access Statistics
    Viewed261    
    Printed48    
    Emailed0    
    PDF Downloaded71    
    Comments [Add]    

Recommend this journal